{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:59:23Z","timestamp":1790297963864,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Colorectal cancer (CRC) develops through a series of progressive genetic mutations, with alterations in\n                    <jats:italic>APC<\/jats:italic>\n                    and\n                    <jats:italic>TP53<\/jats:italic>\n                    being the most frequently observed in the early stages. Although the loss of\n                    <jats:italic>APC<\/jats:italic>\n                    is recognized as a significant initiating event, the epigenetic processes through which the simultaneous inactivation of\n                    <jats:italic>APC<\/jats:italic>\n                    and\n                    <jats:italic>TP53<\/jats:italic>\n                    facilitates the onset of colorectal tumorigenesis remain poorly characterized. To address this gap, we developed a human colon organoid model using CRISPR-Cas9 to achieve a double knockout of\n                    <jats:italic>APC<\/jats:italic>\n                    and\n                    <jats:italic>TP53<\/jats:italic>\n                    . Through extensive multi-omics profiling, we characterized the epigenetic landscape distinctive of early-stage CRC. We identified\n                    <jats:italic>KIT<\/jats:italic>\n                    , a receptor tyrosine kinase, as a critical oncogenic driver that is significantly upregulated in \u0394DKO (\n                    <jats:italic>APC<\/jats:italic>\n                    and\n                    <jats:italic>TP53<\/jats:italic>\n                    double knockout) organoids, thereby activating the MAPK and Wnt signaling pathways to augment proliferation and tumorigenesis. Furthermore, AP-1 transcription factors (FOS\/JUN) regulate\n                    <jats:italic>KIT<\/jats:italic>\n                    expression via chromatin remodeling. Functional analyses indicated that KIT is integral to sustaining the elevated proliferation rates observed in \u0394DKO organoids. These findings reveal a novel AP-1\/KIT signaling axis that is central to the early progression of CRC, thereby presenting a promising avenue for therapeutic intervention.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-09056-7","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:56:25Z","timestamp":1783140985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Activation of KIT signaling promotes early tumorigenesis through the AP-1 pathway in APC\/TP53 double-knockout human colon organoids"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8806-8845","authenticated-orcid":false,"given":"Younghee","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Yeon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngwon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hyun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6039-6336","authenticated-orcid":false,"given":"Tae-You","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"key":"9056_CR1","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","volume":"61","author":"ER Fearon","year":"1990","unstructured":"Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759\u201367.","journal-title":"Cell"},{"key":"9056_CR2","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1056\/NEJMra0804588","volume":"361","author":"SD Markowitz","year":"2009","unstructured":"Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med. 2009;361:2449\u201360.","journal-title":"N Engl J Med"},{"key":"9056_CR3","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.4161\/cc.8.16.9278","volume":"8","author":"RA Phelps","year":"2009","unstructured":"Phelps RA, Broadbent TJ, Stafforini DM, Jones DA. New perspectives on APC control of cell fate and proliferation in colorectal cancer. Cell Cycle. 2009;8:2549\u201356.","journal-title":"Cell Cycle"},{"key":"9056_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-pathol-011110-130235","volume":"6","author":"ER Fearon","year":"2011","unstructured":"Fearon ER. Molecular Genetics of Colorectal Cancer. Annu Rev Pathol Mech Dis. 2011;6:479\u2013507.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"9056_CR5","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330\u20137.","DOI":"10.1038\/nature11252"},{"key":"9056_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/humu.10175","volume":"21","author":"B Iacopetta","year":"2003","unstructured":"Iacopetta B. TP53 mutation in colorectal cancer. Hum Mutat. 2003;21:271\u20136.","journal-title":"Hum Mutat"},{"key":"9056_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41418-024-01259-9","volume":"32","author":"A Janic","year":"2025","unstructured":"Janic A, Abad E, Amelio I. Decoding p53 tumor suppression: a crosstalk between genomic stability and epigenetic control? Cell Death Differ. 2025;32:1\u20138.","journal-title":"Cell Death Differ"},{"key":"9056_CR8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41392-022-01024-9","volume":"7","author":"X-Y Tang","year":"2022","unstructured":"Tang X-Y, Wu S, Wang D, Chu C, Hong Y, Tao M, et al. Human organoids in basic research and clinical applications. Signal Transduct Target Ther. 2022;7:168.","journal-title":"Signal Transduct Target Ther"},{"key":"9056_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","volume":"21","author":"J Kim","year":"2020","unstructured":"Kim J, Koo B-K, Knoblich JA. Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol. 2020;21:571\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9056_CR10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s43018-020-0102-y","volume":"1","author":"YH Lo","year":"2020","unstructured":"Lo YH, Karlsson K, Kuo CJ. Applications of Organoids for Cancer Biology and Precision Medicine. Nat Cancer. 2020;1:761\u201373.","journal-title":"Nat Cancer"},{"key":"9056_CR11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41576-018-0051-9","volume":"19","author":"G Rossi","year":"2018","unstructured":"Rossi G, Manfrin A, Lutolf MP. Progress and potential in organoid research. Nat Rev Genet. 2018;19:671\u201387.","journal-title":"Nat Rev Genet"},{"key":"9056_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","volume":"18","author":"J Drost","year":"2018","unstructured":"Drost J, Clevers H. Organoids in cancer research. Nat Rev Cancer. 2018;18:407\u201318.","journal-title":"Nat Rev Cancer"},{"key":"9056_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/science.aal2380","volume":"357","author":"WA Flavahan","year":"2017","unstructured":"Flavahan WA, Gaskell E, Bernstein BE. Epigenetic plasticity and the hallmarks of cancer. Science. 2017;357:eaal2380.","journal-title":"Science"},{"key":"9056_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-014-0077-3","volume":"6","author":"KJ Kron","year":"2014","unstructured":"Kron KJ, Bailey SD, Lupien M. Enhancer alterations in cancer: a source for a cell identity crisis. Genome Med. 2014;6:77.","journal-title":"Genome Med"},{"key":"9056_CR15","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.cell.2017.07.007","volume":"170","author":"JS Roe","year":"2017","unstructured":"Roe JS, Hwang CI, Somerville TDD, Milazzo JP, Lee EJ, Da Silva B, et al. Enhancer reprogramming promotes pancreatic cancer metastasis. Cell. 2017;170:875\u201388.e20.","journal-title":"Cell"},{"key":"9056_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22544-y","volume":"12","author":"G Della Chiara","year":"2021","unstructured":"Della Chiara G, Gervasoni F, Fakiola M, Godano C, D\u2019Oria C, Azzolin L, et al. Epigenomic landscape of human colorectal cancer unveils an aberrant core of pan-cancer enhancers orchestrated by YAP\/TAZ. Nat Commun. 2021;12:2340.","journal-title":"Nat Commun"},{"key":"9056_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21707-1","volume":"12","author":"LK Gopi","year":"2021","unstructured":"Gopi LK, Kidder BL. Integrative pan cancer analysis reveals epigenomic variation in cancer type and cell specific chromatin domains. Nat Commun. 2021;12:1419.","journal-title":"Nat Commun"},{"key":"9056_CR18","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1002\/1878-0261.13144","volume":"16","author":"YW Cho","year":"2022","unstructured":"Cho YW, Min DW, Kim HP, An Y, Kim S, Youk J, et al. Patient-derived organoids as a preclinical platform for precision medicine in colorectal cancer. Mol Oncol. 2022;16:2396\u2013412.","journal-title":"Mol Oncol"},{"key":"9056_CR19","doi-asserted-by":"crossref","unstructured":"Mihara E, Hirai H, Yamamoto H, Tamura-Kawakami K, Matano M, Kikuchi A, et al. Active and water-soluble form of lipidated Wnt protein is maintained by a serum glycoprotein afamin\/\u03b1-albumin. Elife. 2016;5:e11621.","DOI":"10.7554\/eLife.11621"},{"key":"9056_CR20","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/nar\/gkv933","volume":"44","author":"J Yun","year":"2016","unstructured":"Yun J, Song SH, Kang JY, Park J, Kim HP, Han SW, et al. Reduced cohesin destabilizes high-level gene amplification by disrupting pre-replication complex bindings in human cancers with chromosomal instability. Nucleic Acids Res. 2016;44:558\u201372.","journal-title":"Nucleic Acids Res"},{"key":"9056_CR21","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1038\/onc.2013.285","volume":"33","author":"HP Kim","year":"2014","unstructured":"Kim HP, Han SW, Song SH, Jeong EG, Lee MY, Hwang D, et al. Testican-1-mediated epithelial\u2013mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer. Oncogene. 2014;33:3334\u201341.","journal-title":"Oncogene"},{"key":"9056_CR22","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.stem.2013.11.002","volume":"13","author":"G Schwank","year":"2013","unstructured":"Schwank G, Koo B-K, Sasselli V, Dekkers JohannaF, Heo I, Demircan T, et al. Functional repair of CFTR by CRISPR\/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell. 2013;13:653\u20138.","journal-title":"Cell Stem Cell"},{"key":"9056_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature14415","volume":"521","author":"J Drost","year":"2015","unstructured":"Drost J, van Jaarsveld RH, Ponsioen B, Zimberlin C, van Boxtel R, Buijs A, et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature. 2015;521:43\u20137.","journal-title":"Nature"},{"key":"9056_CR24","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1128\/MCB.22.4.1172-1183.2002","volume":"22","author":"EH Jho","year":"2002","unstructured":"Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt\/beta-catenin\/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 2002;22:1172\u201383.","journal-title":"Mol Cell Biol"},{"key":"9056_CR25","doi-asserted-by":"publisher","first-page":"744","DOI":"10.21037\/jgo-23-49","volume":"14","author":"S He","year":"2023","unstructured":"He S, Li X, Zhou X, Weng W, Lai J. Role of epithelial cell-mesenchymal transition regulators in molecular typing and prognosis of colon cancer. J Gastrointest Oncol. 2023;14:744\u201357.","journal-title":"J Gastrointest Oncol"},{"key":"9056_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52816-z","volume":"9","author":"T Ieda","year":"2019","unstructured":"Ieda T, Tazawa H, Okabayashi H, Yano S, Shigeyasu K, Kuroda S, et al. Visualization of epithelial-mesenchymal transition in an inflammatory microenvironment\u2013colorectal cancer network. Sci Rep. 2019;9:16378.","journal-title":"Sci Rep"},{"key":"9056_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41392-025-02142-w","volume":"10","author":"C Xue","year":"2025","unstructured":"Xue C, Chu Q, Shi Q, Zeng Y, Lu J, Li L. Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances. Signal Transduct Target Ther. 2025;10:106.","journal-title":"Signal Transduct Target Ther"},{"key":"9056_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/CMAR.S411168","volume":"15","author":"K He","year":"2023","unstructured":"He K, Gan WJ. Wnt\/beta-catenin signaling pathway in the development and progression of colorectal cancer. Cancer Manag Res. 2023;15:435\u201348.","journal-title":"Cancer Manag Res"},{"key":"9056_CR29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2108408119","volume":"119","author":"AR Moshkovsky","year":"2022","unstructured":"Moshkovsky AR, Kirschner MW. The nonredundant nature of the Axin2 regulatory network in the canonical Wnt signaling pathway. Proc Natl Acad Sci. 2022;119:e2108408119.","journal-title":"Proc Natl Acad Sci"},{"key":"9056_CR30","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1126\/science.290.5493.989","volume":"290","author":"L Zhang","year":"2000","unstructured":"Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B. Role of BAX in the apoptotic response to anticancer agents. Science. 2000;290:989\u201392.","journal-title":"Science"},{"key":"9056_CR31","doi-asserted-by":"publisher","first-page":"995","DOI":"10.7150\/ijms.42805","volume":"17","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Bo Z, Gong W, Guo Y. Inhibitor of differentiation 1 (Id1) in cancer and cancer therapy. Int J Med Sci. 2020;17:995\u20131005.","journal-title":"Int J Med Sci"},{"key":"9056_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7840","volume":"6","author":"M Papaspyridonos","year":"2015","unstructured":"Papaspyridonos M, Matei I, Huang Y, do Rosario Andre M, Brazier-Mitouart H, Waite JC, et al. Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation. Nat Commun. 2015;6:6840.","journal-title":"Nat Commun"},{"key":"9056_CR33","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","volume":"29","author":"K Engeland","year":"2022","unstructured":"Engeland K. Cell cycle regulation: p53-p21-RB signaling. Cell Death Differ. 2022;29:946\u201360.","journal-title":"Cell Death Differ"},{"key":"9056_CR34","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nature06196","volume":"449","author":"N Barker","year":"2007","unstructured":"Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449:1003\u20137.","journal-title":"Nature"},{"key":"9056_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s004330050101","volume":"198","author":"S Bekku","year":"1998","unstructured":"Bekku S, Mochizuki H, Takayama E, Shinomiya N, Fukamachi H, Ichinose M, et al. Carbonic anhydrase I and II as a differentiation marker of human and rat colonic enterocytes. Res Exp Med (Berl). 1998;198:175\u201385.","journal-title":"Res Exp Med (Berl)"},{"key":"9056_CR36","doi-asserted-by":"publisher","first-page":"27037","DOI":"10.18632\/oncotarget.4815","volume":"6","author":"J Tan","year":"2015","unstructured":"Tan J, Yang S, Shen P, Sun H, Xiao J, Wang Y, et al. C-kit signaling promotes proliferation and invasion of colorectal mucinous adenocarcinoma in a murine model. Oncotarget. 2015;6:27037\u201348.","journal-title":"Oncotarget"},{"key":"9056_CR37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1053\/j.gastro.2015.05.042","volume":"149","author":"EC Chen","year":"2015","unstructured":"Chen EC, Karl TA, Kalisky T, Gupta SK, O\u2019Brien CA, Longacre TA, et al. KIT signaling promotes growth of colon xenograft tumors in mice and is up-regulated in a subset of human colon cancers. Gastroenterology. 2015;149:705\u201317.e2.","journal-title":"Gastroenterology"},{"key":"9056_CR38","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41419-022-05078-z","volume":"13","author":"E K\u00fc\u00e7\u00fckk\u00f6se","year":"2022","unstructured":"K\u00fc\u00e7\u00fckk\u00f6se E, Peters NA, Ubink I, van Keulen VAM, Daghighian R, Verheem A, et al. KIT promotes tumor stroma formation and counteracts tumor-suppressive TGF\u03b2 signaling in colorectal cancer. Cell Death Dis. 2022;13:617.","journal-title":"Cell Death Dis"},{"key":"9056_CR39","doi-asserted-by":"publisher","first-page":"435","DOI":"10.7150\/ijbs.6087","volume":"9","author":"J Liang","year":"2013","unstructured":"Liang J, Wu YL, Chen BJ, Zhang W, Tanaka Y, Sugiyama H. The C-kit receptor-mediated signal transduction and tumor-related diseases. Int J Biol Sci. 2013;9:435\u201343.","journal-title":"Int J Biol Sci"},{"key":"9056_CR40","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/sj.jid.5700125","volume":"126","author":"V Alexeev","year":"2006","unstructured":"Alexeev V, Yoon K. Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes. J Investig Dermatol. 2006;126:1102\u201310.","journal-title":"J Investig Dermatol"},{"key":"9056_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1755-148X.2008.00519.x","volume":"22","author":"S Jeon","year":"2009","unstructured":"Jeon S, Kim N-H, Kim J-Y, Lee A-Y. Stem cell factor induces ERM proteins phosphorylation through PI3K activation to mediate melanocyte proliferation and migration. Pigment Cell Melanoma Res. 2009;22:77\u201385.","journal-title":"Pigment Cell Melanoma Res"},{"key":"9056_CR42","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/onc.2012.562","volume":"33","author":"JR Todd","year":"2014","unstructured":"Todd JR, Scurr LL, Becker TM, Kefford RF, Rizos H. The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanoma. Oncogene. 2014;33:236\u201345.","journal-title":"Oncogene"},{"key":"9056_CR43","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jcmgh.2020.04.007","volume":"10","author":"A Prossomariti","year":"2020","unstructured":"Prossomariti A, Piazzi G, Alquati C, Ricciardiello L. Are Wnt\/\u03b2-catenin and PI3K\/AKT\/mTORC1 distinct pathways in colorectal cancer? Cell Mol Gastroenterol Hepatol. 2020;10:491\u2013506.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"9056_CR44","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1038\/emboj.2009.153","volume":"28","author":"R Sancho","year":"2009","unstructured":"Sancho R, Nateri AS, de Vinuesa AG, Aguilera C, Nye E, Spencer-Dene B, et al. JNK signalling modulates intestinal homeostasis and tumourigenesis in mice. EMBO J. 2009;28:1843\u201354.","journal-title":"EMBO J"},{"key":"9056_CR45","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0092-8674(02)01014-0","volume":"111","author":"M van de Wetering","year":"2002","unstructured":"van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, et al. The beta-catenin\/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 2002;111:241\u201350.","journal-title":"Cell"},{"key":"9056_CR46","doi-asserted-by":"publisher","first-page":"746","DOI":"10.12688\/f1000research.11034.1","volume":"6","author":"AB Ramakrishnan","year":"2017","unstructured":"Ramakrishnan AB, Cadigan KM. Wnt target genes and where to find them. F1000Res. 2017;6:746.","journal-title":"F1000Res"},{"key":"9056_CR47","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers H, Nusse R. Wnt\/beta-catenin signaling and disease. Cell. 2012;149:1192\u2013205.","journal-title":"Cell"},{"key":"9056_CR48","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/382638a0","volume":"382","author":"J Behrens","year":"1996","unstructured":"Behrens J, von Kries JP, K\u00fchl M, Bruhn L, Wedlich D, Grosschedl R, et al. Functional interaction of \u03b2-catenin with the transcription factor LEF-1. Nature. 1996;382:638\u201342.","journal-title":"Nature"},{"key":"9056_CR49","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693\u2013705.","journal-title":"Cell"},{"key":"9056_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1756-8935-7-33","volume":"7","author":"M Tsompana","year":"2014","unstructured":"Tsompana M, Buck MJ. Chromatin accessibility: a window into the genome. Epigenet Chromat. 2014;7:33.","journal-title":"Epigenet Chromat"},{"key":"9056_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1642-2","volume":"20","author":"Z Li","year":"2019","unstructured":"Li Z, Schulz MH, Look T, Begemann M, Zenke M, Costa IG. Identification of transcription factor binding sites using ATAC-seq. Genome Biol. 2019;20:45.","journal-title":"Genome Biol"},{"key":"9056_CR52","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38:576\u201389.","journal-title":"Mol Cell"},{"key":"9056_CR53","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10555-007-9094-7","volume":"26","author":"F Hillen","year":"2007","unstructured":"Hillen F, Griffioen AW. Tumour vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev. 2007;26:489\u2013502.","journal-title":"Cancer Metastasis Rev"},{"key":"9056_CR54","doi-asserted-by":"publisher","first-page":"6930","DOI":"10.1021\/jm5004733","volume":"57","author":"N Ye","year":"2014","unstructured":"Ye N, Ding Y, Wild C, Shen Q, Zhou J. Small molecule inhibitors targeting activator protein 1 (AP-1). J Med Chem. 2014;57:6930\u201348.","journal-title":"J Med Chem"},{"key":"9056_CR55","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1021\/jm050550d","volume":"49","author":"K Tsuchida","year":"2006","unstructured":"Tsuchida K, Chaki H, Takakura T, Kotsubo H, Tanaka T, Aikawa Y, et al. Discovery of nonpeptidic small-molecule AP-1 inhibitors: lead hopping based on a three-dimensional pharmacophore model. J Med Chem. 2006;49:80\u201391.","journal-title":"J Med Chem"},{"key":"9056_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17289-y","volume":"7","author":"H Makino","year":"2017","unstructured":"Makino H, Seki S, Yahara Y, Shiozawa S, Aikawa Y, Motomura H, et al. A selective inhibition of c-Fos\/activator protein-1 as a potential therapeutic target for intervertebral disc degeneration and associated pain. Sci Rep. 2017;7:16983.","journal-title":"Sci Rep"},{"key":"9056_CR57","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1245\/s10434-011-1572-z","volume":"18","author":"WL Lin","year":"2011","unstructured":"Lin WL, Kuo WH, Chen FL, Lee MY, Ruan A, Tyan YS, et al. Identification of the coexisting HER2 gene amplification and novel mutations in the HER2 protein-overexpressed mucinous epithelial ovarian cancer. Ann Surg Oncol. 2011;18:2388\u201394.","journal-title":"Ann Surg Oncol"},{"key":"9056_CR58","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1440-1827.2005.01868.x","volume":"55","author":"T Yamachika","year":"2005","unstructured":"Yamachika T, Nakanishi H, Yasui K, Ikehara Y, Niwa T, Wanibuchi H, et al. Establishment and characterization of a human colonic mucinous carcinoma cell line with predominant goblet-cell differentiation from liver metastasis. Pathol Int. 2005;55:550\u20137.","journal-title":"Pathol Int"},{"key":"9056_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05078-z","volume":"13","author":"E Kucukkose","year":"2022","unstructured":"Kucukkose E, Peters NA, Ubink I, van Keulen VAM, Daghighian R, Verheem A, et al. KIT promotes tumor stroma formation and counteracts tumor-suppressive TGFbeta signaling in colorectal cancer. Cell Death Dis. 2022;13:617.","journal-title":"Cell Death Dis"},{"key":"9056_CR60","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1152\/physrev.00046.2011","volume":"92","author":"J Lennartsson","year":"2012","unstructured":"Lennartsson J, Ronnstrand L. Stem cell factor receptor\/c-Kit: from basic science to clinical implications. Physiol Rev. 2012;92:1619\u201349.","journal-title":"Physiol Rev"},{"key":"9056_CR61","first-page":"4879","volume":"62","author":"S Attoub","year":"2002","unstructured":"Attoub S, Rivat C, Rodrigues S, Van Bocxlaer S, Bedin M, Bruyneel E, et al. The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy. Cancer Res. 2002;62:4879\u201383.","journal-title":"Cancer Res"},{"key":"9056_CR62","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.pai.0000173054.83414.22","volume":"13","author":"M Miettinen","year":"2005","unstructured":"Miettinen M, Lasota J. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol. 2005;13:205\u201320.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"9056_CR63","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1093\/emboj\/cdf389","volume":"21","author":"S Mathas","year":"2002","unstructured":"Mathas S, Hinz M, Anagnostopoulos I, Krappmann D, Lietz A, Jundt F, et al. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa. B EMBO J. 2002;21:4104\u201313.","journal-title":"B EMBO J"},{"key":"9056_CR64","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.phrs.2017.09.014","volume":"128","author":"D Tewari","year":"2018","unstructured":"Tewari D, Nabavi SF, Nabavi SM, Sureda A, Farooqi AA, Atanasov AG, et al. Targeting activator protein 1 signaling pathway by bioactive natural agents: possible therapeutic strategy for cancer prevention and intervention. Pharm Res. 2018;128:366\u201375.","journal-title":"Pharm Res"},{"key":"9056_CR65","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1158\/0008-5472.CAN-13-3396","volume":"74","author":"C Zhao","year":"2014","unstructured":"Zhao C, Qiao Y, Jonsson P, Wang J, Xu L, Rouhi P, et al. Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer. Cancer Res. 2014;74:3983\u201394.","journal-title":"Cancer Res"},{"key":"9056_CR66","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.bbrc.2018.02.147","volume":"497","author":"H Motomura","year":"2018","unstructured":"Motomura H, Seki S, Shiozawa S, Aikawa Y, Nogami M, Kimura T. A selective c-Fos\/AP-1 inhibitor prevents cartilage destruction and subsequent osteophyte formation. Biochem Biophys Res Commun. 2018;497:756\u201361.","journal-title":"Biochem Biophys Res Commun"},{"key":"9056_CR67","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/cas.12914","volume":"107","author":"D Kamide","year":"2016","unstructured":"Kamide D, Yamashita T, Araki K, Tomifuji M, Tanaka Y, Tanaka S, et al. Selective activator protein-1 inhibitor T-5224 prevents lymph node metastasis in an oral cancer model. Cancer Sci. 2016;107:666\u201373.","journal-title":"Cancer Sci"},{"key":"9056_CR68","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/PAS.0b013e31826c1761","volume":"37","author":"CR Antonescu","year":"2013","unstructured":"Antonescu CR, Romeo S, Zhang L, Nafa K, Hornick JL, Nielsen GP, et al. Dedifferentiation in gastrointestinal stromal tumor to an anaplastic KIT-negative phenotype: a diagnostic pitfall: morphologic and molecular characterization of 8 cases occurring either de novo or after imatinib therapy. Am J Surg Pathol. 2013;37:385\u201392.","journal-title":"Am J Surg Pathol"},{"key":"9056_CR69","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.it.2020.06.010","volume":"41","author":"K Yuki","year":"2020","unstructured":"Yuki K, Cheng N, Nakano M, Kuo CJ. Organoid models of tumor immunology. Trends Immunol. 2020;41:652\u201364.","journal-title":"Trends Immunol"},{"key":"9056_CR70","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/annonc\/mdz031","volume":"30","author":"A Otandault","year":"2019","unstructured":"Otandault A, Anker P, Al Amir Dache Z, Guillaumon V, Meddeb R, Pastor B, et al. Recent advances in circulating nucleic acids in oncology. Ann Oncol. 2019;30:374\u201384.","journal-title":"Ann Oncol"},{"key":"9056_CR71","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","volume":"9","author":"L Ma","year":"2024","unstructured":"Ma L, Guo H, Zhao Y, Liu Z, Wang C, Bu J, et al. Liquid biopsy in cancer: current status, challenges and future prospects. Signal Transduct Target Ther. 2024;9:336.","journal-title":"Signal Transduct Target Ther"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09056-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09056-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09056-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:03:30Z","timestamp":1790294610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09056-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9056"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09056-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"829"}}